Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassen

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|November 15, 2021
Milvexian for the Prevention of Venous ThromboembolismJeffrey I Weitz, John Strony, Walter Ageno, et al.
Scientific Reports|January 12, 2021
Cardioprotective effect of combination therapy by mild hypothermia and local or remote ischemic preconditioning in isolated rat heartsMarie V Hjortbak, Nichlas R Jespersen, Rebekka V Jensen, et al.
Thrombosis Research|May 20, 2008
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.
The British Journal of Surgery|July 1, 1988
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgeryM R Lassen, L C Borris, H M Christiansen, et al.
BMJ (Clinical Research Ed.)|January 28, 2006
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialAlexander T Cohen, Bruce L Davidson, Alexander S Gallus, et al.
Archives of Orthopaedic and Trauma Surgery|January 1, 1989
Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamineM R Lassen, L C Borris, H M Christiansen, et al.
Basic Research in Cardiology|May 26, 2021
Translation of experimental cardioprotective capability of P2Y<sub>12</sub> inhibitors into clinical outcome in patients with ST-elevation myocardial infarctionMarie V Hjortbak, Kevin K W Olesen, Jacob M Seefeldt, et al.
Bioorganic & Medicinal Chemistry|July 26, 2005
Stereochemical determination and bioactivity assessment of (S)-(+)-curcuphenol dimers isolated from the marine sponge Didiscus aceratus and synthesized through laccase biocatalysisRobert H Cichewicz, Laura J Clifford, Peter R Lassen, et al.
Eclinicalmedicine|March 20, 2026
Corrigendum to 'Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial' eClinicalMedicine 2026; 92: 103764Michael R Lassen, Matthew Scarborough, Nigel Gilchrist, et al.
Eclinicalmedicine|March 2, 2026
Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trialMichael R Lassen, Matthew Scarborough, Nigel Gilchrist, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|November 15, 2021
Milvexian for the Prevention of Venous ThromboembolismJeffrey I Weitz, John Strony, Walter Ageno, et al.
Scientific Reports|January 12, 2021
Cardioprotective effect of combination therapy by mild hypothermia and local or remote ischemic preconditioning in isolated rat heartsMarie V Hjortbak, Nichlas R Jespersen, Rebekka V Jensen, et al.
Thrombosis Research|May 20, 2008
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatranG Agnelli, B I Eriksson, A T Cohen, et al.
The British Journal of Surgery|July 1, 1988
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgeryM R Lassen, L C Borris, H M Christiansen, et al.
BMJ (Clinical Research Ed.)|January 28, 2006
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialAlexander T Cohen, Bruce L Davidson, Alexander S Gallus, et al.
Archives of Orthopaedic and Trauma Surgery|January 1, 1989
Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamineM R Lassen, L C Borris, H M Christiansen, et al.
Basic Research in Cardiology|May 26, 2021
Translation of experimental cardioprotective capability of P2Y<sub>12</sub> inhibitors into clinical outcome in patients with ST-elevation myocardial infarctionMarie V Hjortbak, Kevin K W Olesen, Jacob M Seefeldt, et al.
Bioorganic & Medicinal Chemistry|July 26, 2005
Stereochemical determination and bioactivity assessment of (S)-(+)-curcuphenol dimers isolated from the marine sponge Didiscus aceratus and synthesized through laccase biocatalysisRobert H Cichewicz, Laura J Clifford, Peter R Lassen, et al.
Eclinicalmedicine|March 20, 2026
Corrigendum to 'Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial' eClinicalMedicine 2026; 92: 103764Michael R Lassen, Matthew Scarborough, Nigel Gilchrist, et al.
Eclinicalmedicine|March 2, 2026
Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trialMichael R Lassen, Matthew Scarborough, Nigel Gilchrist, et al.
Pageof 14